Rapport Therapeutics, Inc.

RAPP · Nasdaq · SIC 2834: Pharmaceutical Preparations
32
SEC Filings

Business Summary

5 Item 1A. Risk Factors 43 Item 1B. Unresolved Staff Comments 97 Item 1C. Cybersecurity 97 Item 2. Properties 98 Item 3. Legal Proceedings 98 Item 4. Mine Safety Disclosures 98 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 99 Item 6. [Reserved] 99 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 100 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 114 Item ...

Next Earnings

Q2 FY2026 — expected 2026-09-07

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionRAPPdiscussed_in_filing Cybersecurity
topic_mentionRAPPdiscussed_in_filing Cybersecurity
topic_mentionRAPPdiscussed_in_filing Cybersecurity
topic_mentionRAPPdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-102025-12-310001193125-26-099360EDGAR108K words
2025-03-112024-12-310000950170-25-036828EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001193125-25-268096EDGAR74K words
2025-08-072025-06-300000950170-25-104565EDGAR—
2025-05-082025-03-310000950170-25-066393EDGAR—
2024-11-072024-09-300000950170-24-122801EDGAR—
2024-08-082024-06-300000950170-24-093334EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-100001193125-26-099336EDGAR3K words
2026-01-070001193125-26-005499EDGAR—
2026-01-070001193125-26-005446EDGAR—
2025-11-060001193125-25-268072EDGAR—
2025-09-100001193125-25-200205EDGAR—
2025-09-080001193125-25-198322EDGAR—
2025-09-080001193125-25-197610EDGAR—
2025-08-070000950170-25-104557EDGAR—
2025-06-180000950170-25-087921EDGAR—
2025-06-020000950170-25-080247EDGAR—

32 total filings indexed. 15 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0002012593
TickerRAPP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 45729d224a62b9c595417d1809c3f43bbf8bc98d1fbac958f431c444ad158ef0
parent: 28a5c497f2bee0d9c60e10d27116fba3afb73a5350d661ff274b63e067189c34
content hash: d81f83785be31b9f7122f8b05f8d735a39490481f2472adf3ad8bd411dffd15e
signed: 2026-04-13T04:47:07.341Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf